Cargando…
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials hav...
Autores principales: | Ko, Seung-Hyun, Hur, Kyu-Yeon, Rhee, Sang Youl, Kim, Nan-Hee, Moon, Min Kyong, Park, Seok-O, Lee, Byung-Wan, Kim, Hyun Jin, Choi, Kyung Mook, Kim, Jin Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663672/ https://www.ncbi.nlm.nih.gov/pubmed/29086531 http://dx.doi.org/10.4093/dmj.2017.41.5.337 |
Ejemplares similares
-
Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017) -
Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017) -
Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017) -
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017) -
Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)